MedicaidCoverageMedium impact
Newsletter Vol. 12, No. 102
New Jersey Medicaid·NJ·Pharmacy
We identified it
Jun 20, 2026
Summary
New Jersey has updated its Medicaid and NJ FamilyCare Drug Rebate Programs by adding and removing pharmaceutical manufacturers from the approved labeler code list (Appendix F). This affects which drug manufacturers are eligible for rebate programs and may impact prescription coverage and reimbursement.
Action Required
Immediately: Pharmacy and billing teams should review the updated Appendix F manufacturer labeler code list to identify which pharmaceutical companies have been added or removed from the rebate program. Verify current drug formularies align with approved manufacturers and update prescription processing systems accordingly to ensure proper coverage verification for NJ Medicaid patients.